Turkish thoracic journal · 2021
High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guia Miguel, Alpay Nilgun, Gerardo António, Madney Yasmin, Abdelrahim Mohamed, Saeed Haitham, Harb Hadeer, Gonçalves Gil, Cabrita Bruno, Alqahtani Jaber, El-Khatib Mohamad, Gómez-Ríos Manuel, Fakharian Atefeh, Ciobanu Laura, Karim Habib Md Reazaul, Piervincenzi Edoardo, Scharffenberg Martin, Steiropoulos Paschalis, LeMaster William, Barjaktarevic Igor, Wittenstein Jakob, Diaz-Abad Montserrat, Perren Andreas, Nicolini Antonello, Spadaro Savino, Garuti Giancarlo, Petroianni Angelo, Esquinas Antonio
Аннотация
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.